Analytical validation of Exandra: a clinical decision support system for promoting guideline-directed therapy of type-2 diabetes in primary care – a collaborative study with experts from Diabetes Canada
Exandra displayed a high level of accuracy and precision in providing guideline-directed recommendations for managing T2D and its common comorbidities. The results of this study indicate that Exandra is a promising tool for improving the management of T2D and its comorbidities.
Authors
- Pedram Shokouh (ORCID: https://orcid.org/0000-0002-4514-0045)
- Ahmad Alhussein (ORCID: https://orcid.org/0000-0003-1000-8308)
- Klaudia Grechuta (ORCID: https://orcid.org/0000-0002-4954-1372)
- Susie Jin (ORCID: https://orcid.org/0000-0001-9284-9324)
- Jeremy Gilbert (ORCID: https://orcid.org/0000-0001-7456-9396)
- H C Kraemer
- Valentina Bayer
Institutions
- Sunnybrook Health Science Centre (CA)
- Boehringer Ingelheim (Germany) (DE)
- University of Toronto (CA)
- Health Sciences Centre (CA)
- Diabetes Canada (CA)
- Boehringer Ingelheim (Egypt) (EG)
- Boehringer Ingelheim (China) (CN)
- Boehringer Ingelheim (United States) (US)
Publication Details
- Journal
- BMC Medical Informatics and Decision Making
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1186/s12911-025-02881-4
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Diabetes Canada